Literature DB >> 1759185

Limitation of temporary vascular occlusion during aneurysm surgery. Study by intraoperative monitoring of cortical blood flow.

A Ogawa1, H Sato, Y Sakurai, T Yoshimoto.   

Abstract

The limitations of temporary vascular occlusion during aneurysm surgery as evidenced by the postoperative ischemic symptoms in relation to cerebral blood flow were studied. Six of the 39 cases had postoperative ischemic neurological deficit. When residual cerebral blood flow was below 15 mL/min/100 g, transient symptoms were seen when temporary clipping was for 10-20 minutes. When more than 20 minutes of clipping was required, irreversible deficits were found. Correlations between residual cerebral blood flow, duration of temporary clipping, and postoperative ischemic symptoms were found. The monitoring of cortical cerebral blood flow is an effective means for determining the limits of temporary vascular occlusion.

Entities:  

Mesh:

Year:  1991        PMID: 1759185     DOI: 10.1016/0090-3019(91)90159-7

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  3 in total

1.  A prediction of postoperative neurological deficits following intracranial aneurysm surgery using somatosensory evoked potential deterioration duration.

Authors:  Mingran Wang; Zhibao Li; Xing Fan; Xiaorong Tao; Lei Qi; Miao Ling; Dongze Guo; Hui Qiao
Journal:  Neurosurg Rev       Date:  2019-01-12       Impact factor: 3.042

2.  High-flow bypass and wrap-clipping for ruptured blood blister-like aneurysm of the internal carotid artery using intraoperative monitoring of cerebral hemodynamics.

Authors:  Yoshitaka Kubo; Takahiro Koji; Kenji Yoshida; Hideo Saito; Akira Ogawa; Kuniaki Ogasawara
Journal:  Vasc Health Risk Manag       Date:  2015-06-03

Review 3.  Controversies in the anesthetic management of intraoperative rupture of intracranial aneurysm.

Authors:  Tumul Chowdhury; Andrea Petropolis; Marshall Wilkinson; Bernhard Schaller; Nora Sandu; Ronald B Cappellani
Journal:  Anesthesiol Res Pract       Date:  2014-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.